Evercore Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
21,571
-725
-3% -$42.3K 0.02% 196
2025
Q4
$1.2M Buy
22,296
+1,122
+5% +$54K 0.02% 202
2025
Q3
$955K Buy
21,174
+3
+0% +$140 0.01% 225
2025
Q2
$980K Sell
21,171
-484
-2% -$23.8K 0.02% 216
2025
Q1
$1.32M Sell
21,655
-7,553
-26% -$440K 0.02% 200
2024
Q4
$1.65M Sell
29,208
-667
-2% -$37.3K 0.02% 176
2024
Q3
$1.55M Sell
29,875
-9,589
-24% -$450K 0.02% 184
2024
Q2
$1.64M Sell
39,464
-12,211
-24% -$546K 0.03% 175
2024
Q1
$2.8M Sell
51,675
-10,588
-17% -$539K 0.04% 136
2023
Q4
$3.19M Sell
62,263
-3,329
-5% -$175K 0.05% 125
2023
Q3
$3.81M Sell
65,592
-4,974
-7% -$305K 0.07% 105
2023
Q2
$4.51M Sell
70,566
-2,302
-3% -$154K 0.08% 99
2023
Q1
$5.05M Sell
72,868
-2,071
-3% -$146K 0.1% 93
2022
Q4
$5.39M Buy
74,939
+3,839
+5% +$289K 0.11% 86
2022
Q3
$5.05M Buy
71,100
+467
+0.7% +$33.9K 0.11% 85
2022
Q2
$5.44M Sell
70,633
-355
-0.5% -$27K 0.11% 86
2022
Q1
$5.18M Sell
70,988
-3,000
-4% -$201K 0.09% 99
2021
Q4
$4.61M Sell
73,988
-6,238
-8% -$366K 0.08% 113
2021
Q3
$4.75M Sell
80,226
-5,069
-6% -$334K 0.09% 107
2021
Q2
$5.7M Sell
85,295
-3,303
-4% -$215K 0.1% 100
2021
Q1
$5.59M Sell
88,598
-3,199
-3% -$199K 0.11% 101
2020
Q4
$5.69M Sell
91,797
-4,788
-5% -$294K 0.12% 95
2020
Q3
$5.82M Sell
96,585
-6,606
-6% -$398K 0.14% 81
2020
Q2
$6.07M Buy
103,191
+5,733
+6% +$343K 0.16% 77
2020
Q1
$5.43M Sell
97,458
-4,279
-4% -$262K 0.18% 73
2019
Q4
$6.53M Buy
101,737
+10,364
+11% +$594K 0.18% 75
2019
Q3
$4.63M Sell
91,373
-8,621
-9% -$405K 0.14% 95
2019
Q2
$4.54M Sell
99,994
-3
-0% -$140 0.14% 93
2019
Q1
$4.77M Sell
99,997
-5,746
-5% -$286K 0.15% 93
2018
Q4
$5.5M Sell
105,743
-5,719
-5% -$307K 0.21% 76
2018
Q3
$6.92M Sell
111,462
-8,703
-7% -$516K 0.22% 74
2018
Q2
$6.65M Buy
120,165
+7,400
+7% +$400K 0.23% 72
2018
Q1
$7.13M Sell
112,765
-4,095
-4% -$263K 0.27% 67
2017
Q4
$7.16M Sell
116,860
-4,320
-4% -$270K 0.27% 66
2017
Q3
$7.72M Sell
121,180
-175
-0.1% -$10.2K 0.3% 65
2017
Q2
$6.76M Sell
121,355
-5,620
-4% -$306K 0.26% 75
2017
Q1
$6.91M Buy
126,975
+15,248
+14% +$836K 0.27% 75
2016
Q4
$6.53M Buy
111,727
+688
+0.6% +$37.6K 0.27% 75
2016
Q3
$5.99M Buy
111,039
+23,846
+27% +$1.53M 0.25% 77
2016
Q2
$6.41M Sell
87,193
-520
-0.6% -$36.7K 0.28% 72
2016
Q1
$5.6M Sell
87,713
-799
-0.9% -$50.4K 0.25% 80
2015
Q4
$6.09M Sell
88,512
-7,795
-8% -$515K 0.28% 76
2015
Q3
$5.71M Buy
96,307
+23,663
+33% +$1.5M 0.27% 79
2015
Q2
$4.84M Sell
72,644
-2,179
-3% -$144K 0.22% 93
2015
Q1
$4.83M Buy
74,823
+2,372
+3% +$148K 0.22% 98
2014
Q4
$4.28M Sell
72,451
-1,526
-2% -$86.1K 0.21% 94
2014
Q3
$3.79M Buy
73,977
+10,390
+16% +$519K 0.19% 106
2014
Q2
$3.09M Buy
63,587
+14,616
+30% +$720K 0.16% 115
2014
Q1
$2.54M Buy
48,971
+9,526
+24% +$507K 0.14% 123
2013
Q4
$2.1M Sell
39,445
-30,580
-44% -$1.56M 0.12% 135
2013
Q3
$3.24M Sell
70,025
-3,877
-5% -$170K 0.19% 124
2013
Q2
$3.31M Buy
+73,902
New +$3.21M 0.19% 125

Other funds holding BMY

Evercore Wealth Management's BMY Position: Q1 2026 in Review

Evercore Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 3.3% in Q1 2026, selling an estimated $42.3K and leaving 21,571 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #196.

Evercore Wealth Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.72M in Q3 2017. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Evercore Wealth Management held 21,571 shares of Bristol-Myers Squibb worth $1.31M as of Q1 2026.
  • Evercore Wealth Management sold 725 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.3K.
  • Bristol-Myers Squibb made up 0.02% of Evercore Wealth Management's portfolio in Q1 2026, its #196 holding.
  • Evercore Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Evercore Wealth Management's Bristol-Myers Squibb position peaked at $7.72M in Q3 2017.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Evercore Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.